1300031-62-2

Basic information

• Product Name: 3,5-dimethyl-4-[2-(methyloxy)-5-nitrophenyl]isoxazole
• Synonyms: 3,5-dimethyl-4-[2-(methyloxy)-5-nitrophenyl]isoxazole
• CAS NO: 1300031-62-2
• Molecular Weight: 248.238
• Mol File: 1300031-62-2.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: 3,5-dimethyl-4-[2-(methyloxy)-5-nitrophenyl]isoxazole(CAS DataBase Reference)
• NIST Chemistry Reference: 3,5-dimethyl-4-[2-(methyloxy)-5-nitrophenyl]isoxazole(1300031-62-2)
• EPA Substance Registry System: 3,5-dimethyl-4-[2-(methyloxy)-5-nitrophenyl]isoxazole(1300031-62-2)

Safety Data

• Hazardous Substances Data: 1300031-62-2(Hazardous Substances Data)

Upstream product

• 10558-25-5 4-bromo-3,5-dimethyl-1,2-oxazole 
• 16114-47-9 3,5-dimethylisoxazole-4-boronic acid 
• 5399-03-1 2-iodo-1-methoxy-4-nitrobenzene 

Downstream Products

• 1300031-49-5 I-BET151 
• 1300031-61-1 [3-(3,5-dimethyl-4-isoxazolyl)-4-(methyloxy)phenyl]amine 
• 1300031-60-0 1,3-diethyl 2-([[3-(3,5-dimethyl-1,2-oxazol-4-yl)-4-methoxyphenyl]amino]methylidene)propanedioate 
• 1300031-57-5 4-chloro-7-(3,5-dimethyl-4-isoxazolyl)-6-(methyloxy)-3-quinolinecarboxamide 
• 1300737-57-8 Ethyl 4-{[2-(1,1-di methylethyl)phenyl]amino}-7-(3,5-dimethyl-4-isoxazolyl)-6-(methoxy)-3-quinolinecarboxylate 
• 1300737-63-6 4-{[2-(1,1-dimethylethyl)phenyl]amino}-7-(3,5-dimethyl-4-isoxazolyl)-6-(methoxy)-3-quinolinecarboxylic acid hydrochloride 
• 1300737-69-2 7-(3,5-dimethyl-4-isoxazolyl)-6-(methyloxy)-4-{[(1R)-1-(2-pyridinyl)ethyl]amino}-3-quinolinecarboxamide 
• 1300736-25-7 7-(3,5-dimethylisoxazol-4-yl)-8-methoxy-1-((R)-1-phenylethyl)-1H-imidazo[4,5-c]quinoline-2(3H)-thione 
• 1300031-63-3 7-(3,5-dimethylisoxazol-4-yl)-6-methoxy-N⁴-((R)-1-phenylethyl)quinoline-3,4-diamine 
• 1300031-64-4 7-(3,5-dimethylisoxazol-4-yl)-6-methoxy-3-nitro-N-((R)-1-phenylethyl)quinolin-4-amine 
• 1403491-64-4 7-(3,5-dimethyl-4-isoxazolyl)-8-(methyloxy)-1-[(1R)-1-phenylethyl]-2-(1-piperidinyl)-1H-imidazo[4,5-c]quinoline 

Relevant articles and documents

METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE

The present disclosure relates to compounds and methods for modulating the expression of dmpk, and treating diseases and conditions in which dmpk plays an active role. The compound can be a transcription modulator molecule having a first terminus, a second terminus, and oligomeric backbone, wherein: a) the first terminus comprises a DNA-binding moiety capable of noncovalently binding to a nucleotide repeat sequence CAG or CTG; b) the second terminus comprises a protein-binding moiety binding to a regulatory molecule that modulates an expression of a gene comprising the nucleotide repeat sequence CAG or CTG; and c) the oligomeric backbone comprising a linker between the first terminus and the second terminus.

7-(3,5-Dimethyl-4-Isoxazolyl)-8-(Methyloxy)-1H-Imidazo[4,5-C]Quinoline Derivatives

Novel quinoline compounds pharmaceutical compositions containing such compounds and their use in therapy.

NOVEL COMPOUNDS

Novel quinoline compounds pharmaceutical compositions containing such compounds and their use in therapy.